Introduction {#H1-1-ZOI190335}
============

The increasing average life expectancy has contributed to aging of the world's population.^[@zoi190335r1]^ By 2050, approximately 21.3% of the global population will be 60 years or older,^[@zoi190335r2]^ up from 9.2% in 1990. Frailty, a clinical syndrome characterized by marked vulnerability due to decline in reserve and function across multiple physiologic systems, is common among older people.^[@zoi190335r3],[@zoi190335r4]^ Frailty manifests as the inability to tolerate stressful events and has been associated with adverse outcomes, such as falls,^[@zoi190335r5]^ delirium,^[@zoi190335r6]^ institutionalization,^[@zoi190335r7]^ incident disability,^[@zoi190335r8]^ and mortality.^[@zoi190335r9]^ Frailty is also an independent risk factor for poor outcomes after surgery (eg, prolonged hospitalizations, increased susceptibility to deconditioning, and faster functional decline)^[@zoi190335r10]^ and is associated with higher health care use^[@zoi190335r11]^ and corresponding costs.^[@zoi190335r12]^ There is a growing interest among stakeholders in aged care to better understand the patterns and determinants of frailty.^[@zoi190335r13]^

Frailty is difficult to diagnose, particularly within primary care settings, due to its coexistence with other age-related conditions and as a result of the lack of a universally accepted clinical definition.^[@zoi190335r14],[@zoi190335r15]^ There is also debate about frailty screening, especially in relation to screening eligibility, as well as where and when it should be done.^[@zoi190335r16]^

Frailty phenotype and deficit accumulation are 2 main approaches to frailty assessment.^[@zoi190335r4]^ Using the phenotype approach, Fried et al^[@zoi190335r17]^ defined frailty as a predominantly physical condition requiring the presence of 3 or more of the following 5 components: weight loss, exhaustion, weakness, slowness, and low physical activity. However, Rockwood et al^[@zoi190335r18]^ characterized frailty as an accumulation of deficits (symptoms, signs, functional impairment, and laboratory abnormalities) and stipulated that more deficits confer greater risk. These 2 frailty conceptualizations have been extensively validated and are widely used. Beyond these conceptualizations of frailty, several other definitions are present in the literature.^[@zoi190335r19]^ Many definitions consider frailty to be a dynamic process with an identifiable intermediate stage, usually referred to as prefrailty.^[@zoi190335r20]^

Since 2000, frailty-related research has increased exponentially.^[@zoi190335r15]^ Nonetheless, the epidemiological evidence on frailty is dominated by a focus on prevalence. Incidence remains poorly understood. Although Galluzzo et al^[@zoi190335r21]^ previously performed a systematic review on frailty incidence, their analysis focused on European ADVANTAGE Joint Action countries and included 6 studies, with no meta-analysis performed. With a growing worldwide interest in healthy aging,^[@zoi190335r22]^ improved understanding of the incidence of frailty may help deepen the discourse around the maintenance of functional ability in old age. Therefore, we conducted a systematic review and meta-analysis to summarize the available global epidemiological data on the incidence of frailty and prefrailty among community-dwelling adults 60 years or older.

Methods {#H1-2-ZOI190335}
=======

This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses^[@zoi190335r23]^ ([PRISMA](http://www.equator-network.org/reporting-guidelines/prisma/)) and Meta-analysis of Observational Studies in Epidemiology^[@zoi190335r24]^ ([MOOSE](https://www.equator-network.org/reporting-guidelines/meta-analysis-of-observational-studies-in-epidemiology-a-proposal-for-reporting-meta-analysis-of-observational-studies-in-epidemiology-moose-group/)) reporting guidelines. The study protocol is registered at PROSPERO (CRD42019121302).^[@zoi190335r25]^

Study Eligibility Criteria {#H2-1-ZOI190335}
--------------------------

Two of us (R.O-A. and K.L.C) independently determined study eligibility, and any disagreements were resolved via consensus involving a third reviewer (D. Liew). The inclusion criteria were cohort studies that reported or had sufficient data to compute incidence of frailty or prefrailty among community-dwelling adults 60 years or older at baseline. Frailty status was considered categorically as robust, prefrail, or frail.^[@zoi190335r26]^ Frailty could have been diagnosed by any method, but studies needed to specify their definition. For the Fried phenotype, individuals are often classified as robust, prefrail, or frail if 0, 1 to 2, or 3 or more of the criteria (ie, weight loss, exhaustion, weakness, slowness, and low physical activity) are met, respectively.^[@zoi190335r17]^ For the deficit accumulation approach, the definitions of robust, prefrail, and frail were as specified by study authors, as has been done previously.^[@zoi190335r27],[@zoi190335r28]^ Incidence of frailty was defined as new cases of frailty among robust or prefrail individuals, and incidence of prefrailty was defined as new cases of prefrailty among robust individuals, both over a specified duration. When multiple studies used the same cohort, the study with the most complete data on the largest number of participants was selected.

Exclusion criteria included studies focusing on institutionalized or hospitalized adults, residents of nursing homes (because these populations are often predominantly frail),^[@zoi190335r29]^ or populations selected on the basis of an index disease. Studies reporting the mean frailty scores but without data on incidence were excluded, as were randomized clinical trials. Studies of individuals across the life span were excluded unless data were specifically available for those 60 years or older at baseline.

Search and Selection of Studies {#H2-2-ZOI190335}
-------------------------------

In the systematic review, 2 of us (R.O-A. and K.L.C.) undertook the search, article screening, and study selection. MEDLINE, Embase, PsycINFO, Web of Science, CINAHL Plus, and AMED (Allied and Complementary Medicine Database) were searched from inception to January 2019 without language restrictions using combinations of the keywords *frailty*, *older adults*, and *incidence*. eTable 1 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"} lists the search terms and strategy for MEDLINE (via Ovid), which were adapted for other databases. The reference lists of eligible studies were hand searched. Conference abstracts, editorials, and meeting reports were excluded.

Study Quality Assessment and Data Extraction {#H2-3-ZOI190335}
--------------------------------------------

Two of us (R.O-A. and K.L.C.) evaluated each included study for methodological quality using The Joanna Briggs Institute's Critical Appraisal Checklist for Prevalence and Incidence Studies.^[@zoi190335r30]^ This checklist consists of 9 criteria, and studies were ineligible if fewer than 5 of the criteria were achieved.

The following information was collected from individual articles: study details (authors, year of publication, country, and study name), participant characteristics (sample size and percentage of women), frailty measurement method, duration of follow-up, and incidence data. Sex-stratified or age-stratified incidence data were collected, where available. Authors were contacted for additional data or clarification, when required.

Statistical Analysis {#H2-4-ZOI190335}
--------------------

For each study, we recorded or calculated incidence rates of frailty or prefrailty per 1000 person-years based on the event rates and the mean duration of follow-up.^[@zoi190335r27],[@zoi190335r31],[@zoi190335r32],[@zoi190335r33]^ Exact methods according to the Poisson distribution were adopted to calculate 95% CIs for incidence rates.^[@zoi190335r34]^ There were 2 kinds of studies, including (1) those that used a 100% survivor cohort (ie, assessed frailty status at 2 time points, excluding persons who died in-between) and (2) those that accounted for people in the cohort who died without developing frailty. Therefore, to improve the comparability of these 2 types of studies, as well as to minimize the consequences of survivorship bias,^[@zoi190335r35]^ we recalculated the incidence rate in the latter studies (ie, studies that reported transition to deaths) by restricting the sample to the surviving cohort with frailty data.^[@zoi190335r27],[@zoi190335r36]^

A random-effects (DerSimonian and Laird) meta-analysis was conducted using the log-transformed incidence rates and corresponding 95% CIs. The random-effects model was selected a priori due to the anticipated heterogeneity of the included studies. Statistical evidence of between-study heterogeneity was examined using the Cochran *Q* test and the *I*^2^ statistic.^[@zoi190335r37]^ *I*^2^ values of 25%, 50%, and 75% were considered to be low, moderate, and high degrees of heterogeneity, respectively.^[@zoi190335r37]^ The robustness of pooled estimates were assessed via leave-1-out sensitivity analyses. A study was considered to be influential if the pooled estimate without it was not within the 95% CIs of the overall pooled estimate. Sex-specific incidence data were pooled, as were the incidence rates by assessment method. To examine the extent to which the pooled incidence rates were explained by these factors, we also performed random-effects meta-regression using the following variables: measurement method (physical phenotype vs other), country income level (lower-income and middle-income country \[LMIC\] vs high-income country \[HIC\]), study region (North America, Europe, Asia, or other), person-years of follow-up (per unit increase), whether the study enrolled only elderly people 70 years or older (no vs yes), study population (mix, female only, or male only), and publication years (2009 or earlier, 2010 to 2014, or 2015 to 2019). The HICs were defined as any country with a gross national income per capita in 2017 of US \$12 056 or more.^[@zoi190335r38]^ Differences between subgroups were compared via a χ^2^ test. Publication bias was assessed via visual inspection of funnel plots, and statistical assessment was evaluated using the Egger test.^[@zoi190335r39]^

To provide context of the burden of frailty, data on the proportion of older adults who were nonfrail were pooled using the respective study baseline data, if reported. The meta-analysis was performed using the Freeman-Tukey double arcsine transformed proportions to stabilize the variance.^[@zoi190335r40]^

All analyses were performed using statistical software (Stata, version 15.0/IC; StataCorp LP). Two-tailed *P* \< .05 was considered statistically significant.

Results {#H1-3-ZOI190335}
=======

Selection Process {#H2-5-ZOI190335}
-----------------

Of 15 176 retrieved citations, 142 articles were selected for full-text assessment ([Figure 1](#zoi190335f1){ref-type="fig"}). After full-text evaluation, 42 studies met the eligibility criteria. Four additional studies were retrieved by reference screening, resulting in a total of 46 studies (involving 48 cohorts) included in the systematic review. No study was excluded on the basis of The Joanna Briggs Institute methodological review.^[@zoi190335r30]^

![PRISMA Diagram of the Study Selection Process\
AMED indicates Allied and Complementary Medicine Database; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.](jamanetwopen-2-e198398-g001){#zoi190335f1}

Study Characteristics {#H2-6-ZOI190335}
---------------------

The characteristics of the 46 included studies are summarized in [Table 1](#zoi190335t1){ref-type="table"}. The studies involved 120 805 nonfrail (robust or prefrail) older adults from 28 countries. Nine studies were from Asia, 14 from North America, 2 from South America, 15 from Europe, and 4 from Australia, and 2 were cross-regional studies. eFigure 1 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"} shows the geographical spread of the countries where data were collected. The median sample size across studies was 1054 (range, 44-28 181), and the median follow-up was 3.0 (range, 1.0-11.7) years. In 30 studies involving 101 259 participants, 73.3% were women. Frailty was assessed using the original or modified versions of the Fried criteria in 39 studies, 4 studies used the Frailty Index, and 1 study used both the Frailty Index and the Fried criteria, whereas 2 studies used other criteria. Among the studies using the deficit accumulation approach, the number of deficits used ranged from 20 to 44.

###### Descriptive Characteristics of 46 Studies Included in the Systematic Review

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source (Study Region)                                                                                                                                                 Study or Cohort Name                                                           Sample Size[^a^](#zoi190335t1n1){ref-type="table-fn"}   Age Range, y           \% Female              Mean Follow-up, y   Frail Diagnostic Criteria                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ------------------------------------------------------- ---------------------- ---------------------- ------------------- --------------------------- ----------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ahmad et al,^[@zoi190335r41]^ 2018 (Malaysia)                                                                                                                         NA                                                                             1677                                                    605                    1072                   ≥60                 61.6                        1.0                                             Fried criteria

  Alencar et al,^[@zoi190335r42]^ 2015 (Brazil)                                                                                                                         NA                                                                             151                                                     43                     108                    ≥65                 NS                          1.0                                             Fried criteria

  Ayers et al,^[@zoi190335r43]^ 2017 (United States)                                                                                                                    A: LonGenity study\                                                            A: 549\                                                 NS                     NS                     ≥65                 NS                          A: 3.18\                                        Fried criteria
                                                                                                                                                                        B: Central Control of Mobility in Aging                                        B: 256                                                                                                                                                B: 1.74                                         

  Baulderstone et al,^[@zoi190335r44]^ 2012 (Australia)                                                                                                                 Australian Longitudinal Study of Aging                                         1298                                                    NS                     NS                     ≥65                 49.0                        8.0                                             Fried criteria

  Bentur et al,^[@zoi190335r45]^ 2016 (Israel)                                                                                                                          Members of Maccabi Healthcare Services                                         161                                                     NS                     NS                     ≥65                 NS                          6.0                                             Vulnerable Elders Survey-13

  Borrat-Besson et al,^[@zoi190335r46]^ 2013 (Sweden, Denmark, Germany, the Netherlands, Belgium, France, Switzerland, Austria, Spain, Italy, Poland, Czech Republic)   SHARE survey                                                                   9416                                                    5307                   4109                   ≥60                 50.5                        4.3                                             Fried criteria

  Castrejón-Pérez et al,^[@zoi190335r47]^ 2017 (Mexico)                                                                                                                 Prospective Mexican Study of Nutritional and Psychosocial Markers of Frailty   237                                                     NS                     NS                     70-95               51.5                        3.0                                             Fried criteria

  Chhetri et al,^[@zoi190335r48]^ 2017 (China)                                                                                                                          Beijing Longitudinal Study of Aging II                                         4378                                                    NS                     NS                     ≥65                 NS                          1.0                                             Frailty Index (32 deficits used: on a scale of 0-1, frailty defined as ≥0.25 deficits)

  Dalrymple et al,^[@zoi190335r49]^ 2013 (United States)                                                                                                                Cardiovascular Health Study                                                    3459                                                    NS                     NS                     ≥65                 100                         3.0                                             Fried criteria

  Doba et al,^[@zoi190335r50]^ 2012 (Japan)                                                                                                                             Health Research Volunteer Study                                                373                                                     NS                     NS                     \>70                54.8                        5.0                                             Canadian Study for Health and Aging--Clinical Frailty Scale

  Doi et al,^[@zoi190335r51]^ 2018 (Japan)                                                                                                                              Obu Study of Health Promotion for the Elderly                                  4322                                                    1978                   2344                   ≥65                 51.9                        4.0                                             Fried criteria

  Ensrud et al,^[@zoi190335r52]^ 2010 (United States)                                                                                                                   Study of Osteoporotic Fractures                                                4551                                                    NS                     NS                     ≥65                 100                         4.5                                             Fried criteria

  Espinoza et al,^[@zoi190335r53]^ 2012 (United States)                                                                                                                 San Antonio Longitudinal Study of Aging                                        507                                                     209                    298                    ≥65                 NS                          6.4                                             Fried criteria

  Gale et al,^[@zoi190335r54]^ 2013 (United Kingdom)                                                                                                                    English Longitudinal Study of Ageing                                           2146                                                    NS                     NS                     ≥60                 54.0                        4.0                                             Fried criteria

  García-Esquinas et al,^[@zoi190335r55]^ 2015 (Spain)                                                                                                                  Toledo Study for Healthy Aging                                                 1289                                                    NS                     NS                     ≥65                 58.4                        3.5                                             Fried criteria

  García-Esquinas et al,^[@zoi190335r56]^ 2016 (France)                                                                                                                 Integrated multidisciplinary approach cohort                                   473                                                     NS                     NS                     ≥65                 37.8                        2.0                                             Fried criteria

  Gill et al,^[@zoi190335r57]^ 2006 (United States)                                                                                                                     Precipitating Events Project                                                   536                                                     167                    369                    ≥70                 NS                          1.5[^b^](#zoi190335t1n2){ref-type="table-fn"}   Fried criteria

  Gnjidic et al,^[@zoi190335r58]^ 2012 (Australia)                                                                                                                      Concord Health and Aging in Men Project                                        1242                                                    NS                     NS                     ≥70                 0                           2.0                                             Fried criteria

  Gomes et al,^[@zoi190335r59]^ 2018 (Colombia, Albania, Brazil, Canada)                                                                                                International Mobility in Aging Study                                          1620                                                    816                    804                    65-74               NS                          2.0                                             Fried criteria

  Gruenewald et al,^[@zoi190335r60]^ 2009 (United States)                                                                                                               MacArthur Study of Successful Aging                                            803                                                     440                    363                    70-79               55.5                        3.0                                             Fried criteria

  Hyde et al,^[@zoi190335r61]^ 2016 (Australia)                                                                                                                         Kimberley Healthy Adults Project in Indigenous Australians                     44                                                      NS                     NS                     ≥60                 NS                          7.0                                             Frailty Index (20 deficits used: on a scale of 0-1, frailty defined as ≥0.2 deficits)

  Iwasaki et al,^[@zoi190335r62]^ 2018 (Japan)                                                                                                                          Niigata Study                                                                  322                                                     NS                     NS                     75                  43.8                        4.2                                             Fried criteria

  Kalyani et al,^[@zoi190335r63]^ 2012 (United States)                                                                                                                  Women's Health and Aging Study II                                              329                                                     NS                     NS                     70-79               100                         8.6                                             Fried criteria

  Kim et al,^[@zoi190335r64]^ 2017 (Japan)                                                                                                                              Otasha-Kenshin study                                                           684                                                     NS                     NS                     ≥75                 100                         4.0                                             Fried criteria

  Lanziotti Azevedo da Silva et al,^[@zoi190335r65]^ 2015 (Brazil)                                                                                                      NA                                                                             173                                                     63                     110                    ≥65                 NS                          1.1                                             Fried criteria

  Lee et al,^[@zoi190335r66]^ 2014 (Hong Kong)                                                                                                                          Mr and Mrs OS                                                                  2893                                                    1336                   1557                   ≥65                 48.1                        2.0                                             Fried criteria

  Liu et al,^[@zoi190335r67]^ 2018 (China)                                                                                                                              Chinese Longitudinal Healthy Longevity Survey                                  7601                                                    2252                   5349                   65-99               NS                          3.0                                             Frailty Index (44 deficits were used: on a scale of 0-1, robust, prefrail, and frail were defined as \<0.1, 0.1-0.21, and \>0.21, respectively)

  Lorenzo-López et al,^[@zoi190335r68]^ 2019 (Spain)                                                                                                                    VERISAÚDE study                                                                519                                                     140                    379                    ≥65                 NS                          1.0                                             Fried criteria

  Ottenbacher et al,^[@zoi190335r69]^ 2009 (United States)                                                                                                              Hispanic Established Populations Epidemiologic Studies of the Elderly          1525                                                    737                    788                    ≥65                 42.0                        10.0                                            Fried criteria

  Pilleron et al,^[@zoi190335r70]^ 2017 (France)                                                                                                                        Three-City Bordeaux Study                                                      1265                                                    NS                     NS                     ≥65                 65.4                        11.7                                            Fried criteria

  Pollack et al,^[@zoi190335r71]^ 2017 (United States)                                                                                                                  Osteoporotic Fractures in Men Study                                            4664                                                    2322                   2342                   ≥65                 0                           4.6                                             Fried criteria

  Potier et al,^[@zoi190335r72]^ 2018 (Belgium)                                                                                                                         NA                                                                             72                                                      28                     44                     ≥70                 NS                          1.33                                            Fried criteria

  Ramsay et al,^[@zoi190335r73]^ 2018 (United Kingdom)                                                                                                                  British Regional Heart Study                                                   1054                                                    NS                     NS                     71-92               0                           3.0                                             Fried criteria

  Sandoval-Insausti et al,^[@zoi190335r74]^ 2016 (Spain)                                                                                                                Seniors-ENRICA                                                                 1822                                                    NS                     NS                     ≥60                 51.3                        3.5                                             Fried criteria

  Saum et al,^[@zoi190335r75]^ 2017 (Germany)                                                                                                                           ESTHER cohort                                                                  1446                                                    NS                     NS                     ≥65                 NS                          3.0                                             Fried criteria

  Semba et al,^[@zoi190335r76]^ 2006 (United States)                                                                                                                    Women's Health and Aging Study I                                               463                                                     NS                     NS                     ≥65                 100                         3.0                                             Fried criteria

  Serra-Prat et al,^[@zoi190335r77]^ 2017 (Spain)                                                                                                                       NA                                                                             252                                                     91                     161                    ≥75                 NS                          1.0[^b^](#zoi190335t1n2){ref-type="table-fn"}   Fried criteria

  Shah et al,^[@zoi190335r78]^ 2018 (United States)                                                                                                                     Health and Retirement Study                                                    6073                                                    NS                     NS                     ≥65                 56.0                        4.0[^c^](#zoi190335t1n3){ref-type="table-fn"}   Fried criteria

  Stephan et al,^[@zoi190335r79]^ 2017 (Germany)                                                                                                                        KORA-Age cohort study                                                          740                                                     218                    522                    ≥65                 NS                          3.0                                             Frailty Index (30 items used: on a scale of 0-1 robust, prefrail, and frailty were defined as \<0.08, 0.08 to \<0.25, and ≥0.25, respectively)

  Swiecicka et al,^[@zoi190335r80]^ 2018 (Italy, Belgium, Poland, United Kingdom, Spain, Hungary, Estonia)                                                              European Male Ageing Study                                                     806                                                     550                    256                    ≥60                 0                           4.3                                             Fried criteria

  Thompson et al,^[@zoi190335r81]^ 2018 (Australia)                                                                                                                     North West Adelaide Health Study                                               Fried criteria: 590\                                    Fried criteria: 233\   Fried criteria: 357\   ≥65                 48.1                        4.5                                             Fried criteria and Frailty Index (30 items used: on a scale of 0-1, robust, prefrail, and frailty were defined as \<0.08, 0.08 to \<0.25, and ≥0.25, respectively)
                                                                                                                                                                                                                                                       Frailty Index: 394                                      Frailty Index: 175     Frailty Index: 219                                                                                                     

  Tom et al,^[@zoi190335r82]^ 2017 (Belgium, Canada, France, Germany, Italy, the Netherlands, Spain, United Kingdom, United States)                                     Global Longitudinal Study of Osteoporosis in Women                             14 752                                                  14 752                 Excluded               ≥60                 100                         2.0                                             Fried criteria

  Trevisan et al,^[@zoi190335r83]^ 2016 (Italy)                                                                                                                         Progetto Veneto Anziani                                                        2702                                                    1261                   1441                   ≥65                 58.7                        4.4                                             Fried criteria

  Wang et al,^[@zoi190335r84]^ 2019 (Taiwan)                                                                                                                            NA                                                                             541                                                     NS                     NS                     65-99               NS                          1.0                                             Fried criteria

  Woods et al,^[@zoi190335r85]^ 2005 (United States)                                                                                                                    Women's Health Initiative Observational Study                                  28 181                                                  NS                     NS                     65-79               100                         3.0                                             Fried criteria

  Zaslavsky et al,^[@zoi190335r86]^ 2016 (United States)                                                                                                                Adult Changes in Thought Study                                                 1848                                                    NS                     NS                     ≥65                 57.9                        4.8                                             Fried criteria
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: NA, not applicable; NS, not specified.

Where available, sample size includes those who died but excludes people lost to follow-up. The total number of nonfrail people across all studies was 120 805.

Data were extracted from the follow-up duration with the most comprehensive data.

We selected the periods with the most comprehensive data as derived from a survival analysis.

In 31 studies, data on baseline proportion of older adults without frailty were available. In these studies, involving 118 411 individuals at baseline, the pooled proportion without frailty was 82.8% (95% CI, 75.8%-88.8%; *I*^2^ = 99.8%). The pooled proportion that was nonfrail was 86.5% (95% CI, 78.9%-92.7%; *I*^2^ = 99.8%) across studies that used the Fried criteria and 58.9% (95% CI, 44.2%-72.8%; *I*^2^ = 99.6%) across studies that used other criteria (*P* for difference \< .001).

Incidence of Frailty {#H2-7-ZOI190335}
--------------------

To estimate the global incidence of frailty, data were included from 46 studies.^[@zoi190335r41],[@zoi190335r42],[@zoi190335r43],[@zoi190335r44],[@zoi190335r45],[@zoi190335r46],[@zoi190335r47],[@zoi190335r48],[@zoi190335r49],[@zoi190335r50],[@zoi190335r51],[@zoi190335r52],[@zoi190335r53],[@zoi190335r54],[@zoi190335r55],[@zoi190335r56],[@zoi190335r57],[@zoi190335r58],[@zoi190335r59],[@zoi190335r60],[@zoi190335r61],[@zoi190335r62],[@zoi190335r63],[@zoi190335r64],[@zoi190335r65],[@zoi190335r66],[@zoi190335r67],[@zoi190335r68],[@zoi190335r69],[@zoi190335r70],[@zoi190335r71],[@zoi190335r72],[@zoi190335r73],[@zoi190335r74],[@zoi190335r75],[@zoi190335r76],[@zoi190335r77],[@zoi190335r78],[@zoi190335r79],[@zoi190335r80],[@zoi190335r81],[@zoi190335r83],[@zoi190335r84],[@zoi190335r85],[@zoi190335r86]^ Among people without frailty at baseline who survived a median follow-up of 3.0 (range, 1.0-11.7) years, 13.6% (13 678 of 100 313) became frail. The pooled incidence rate of frailty was 43.4 (95% CI, 37.3-50.4; *I*^2^ = 98.5%) cases per 1000 person-years ([Figure 2](#zoi190335f2){ref-type="fig"}). There was no evidence of publication bias as determined by funnel plot visualization (eFigure 2 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}) or via the Egger test (*P* = .48). A leave-1-out sensitivity analysis did not show a dominance of any single study (eTable 2 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}).

![Forest Plot of the Incidence Rates (per 1000 Person-Years) of Frailty Among Community-Dwelling Older Adults\
Weights are from random-effects analysis. Forty-five studies were included.](jamanetwopen-2-e198398-g002){#zoi190335f2}

The pooled frailty incidence rate was 40.0 (95% CI, 34.5-48.5; *I*^2^ = 98.2%) cases per 1000 person-years when using the Fried phenotype. The pooled frailty incidence rate was 71.3 (95% CI, 56.9-89.3; *I*^2^ = 94.0%) cases per 1000 person-years when using other criteria (*P* for difference = .003).

Among 20 studies that reported transitions to death, the proportion of nonfrail people who died over a median follow-up of 4.5 years was 12.9% (5989 of 46 358). When factoring in the risk of death, the pooled incidence rate of frailty was 35.9 (95% CI, 28.0-46.1; *I*^2^ = 98.7%) cases per 1000 person-years (eFigure 3 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}). Restricting the analyses to those who survived in these 19 studies resulted in a pooled frailty incidence rate of 44.1 (95% CI, 34.0-57.2; *I*^2^ = 98.8%) cases per 1000 person-years (eFigure 4 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}).

Twenty studies reported the incidence of frailty among 19 613 people who were prefrail and 17 523 people who were robust at baseline and who survived over a median follow-up of 3.0 years. During the follow-up, 4.6% (807 of 17 523) of individuals who were robust and 18.5% (3628 of 19 613) of individuals who were prefrail developed frailty. The pooled frailty incidence rates among the robust and prefrail individuals were 12.0 (95% CI, 8.2-17.5; *I*^2^ = 94.9%) and 62.7 (95% CI, 49.2-79.8; *I*^2^ = 97.8%) cases per 1000 person-years, respectively, with the difference being statistically significant (*P* value for difference \< .001).

Ten studies directly compared frailty incidence between 11 959 men and 13 870 women who survived a median follow-up of 4.0 years. Among the men and women, 9.2% (1099 of 11 959) and 15.6% (2164 of 13 870), respectively, developed frailty. The pooled incidence rates of frailty in men and women in these studies were 24.3 (95% CI, 19.6-30.1; *I*^2^ = 89.4%) and 44.8 (95% CI, 36.7-61.3; *I*^2^ = 97.9%) cases per 1000 person-years, respectively, with the difference being statistically significant (*P* value for difference = .01).

Only 2 studies^[@zoi190335r48],[@zoi190335r75]^ reported age-stratified frailty incidence rate, with inconsistent age groups being used. Therefore, data were not pooled, although both studies reported consistent increases in frailty incidence with increasing age.

Incidence of Prefrailty {#H2-8-ZOI190335}
-----------------------

Twenty-one studies^[@zoi190335r41],[@zoi190335r42],[@zoi190335r46],[@zoi190335r51],[@zoi190335r53],[@zoi190335r57],[@zoi190335r59],[@zoi190335r60],[@zoi190335r65],[@zoi190335r66],[@zoi190335r67],[@zoi190335r68],[@zoi190335r69],[@zoi190335r71],[@zoi190335r72],[@zoi190335r77],[@zoi190335r79],[@zoi190335r80],[@zoi190335r81],[@zoi190335r82],[@zoi190335r83]^ reported data on the global incidence of prefrailty among 32 268 community-dwelling older adults who were robust at baseline and survived a median follow-up of 2.5 (range, 1.0-10.0) years. During the follow-up, 30.9% (9974 of 32 268) became prefrail. The pooled incidence rate of prefrailty was 150.6 (95% CI, 123.3-184.1; *I*^2^ = 98.9%) cases per 1000 person-years ([Figure 3](#zoi190335f3){ref-type="fig"}). There was no evidence of publication bias as determined by visual inspection of funnel plots (eFigure 5 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}) or by means of the Egger test. A leave-1-out sensitivity analysis did not alter the results (eTable 3 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}).

![Forest Plot of the Incidence Rates (per 1000 Person-Years) of Prefrailty Among Community-Dwelling Older Adults\
Weights are from random-effects analysis. Twenty-one studies were included.](jamanetwopen-2-e198398-g003){#zoi190335f3}

The pooled incidence rate of prefrailty was 150.9 (95% CI, 120.2-182.6; *I^2^* = 98.8%) cases per 1000 person-years when using the Fried phenotype. The pooled incidence rate of prefrailty was 140.4 (95% CI, 97.2-202.9; *I^2^* = 93.4%) cases per 1000 person-years when using other criteria (*P* for difference = .52).

Among 13 studies that reported transitions to death, the proportion of robust people who died over a median follow-up of 4.0 years was 7.8% (1253 of 16 134). When factoring in the risk of death, the pooled incidence rate of prefrailty was 110.6 (95% CI, 84.8-144.2; *I*^2^ = 98.9%) cases per 1000 person-years (eFigure 6 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}). Restricting the analyses to those who survived in these 13 studies resulted in a pooled prefrailty incidence rate of 122.7 (95% CI, 95.7-157.5; *I*^2^ = 98.7%) cases per 1000 person-years (eFigure 7 in the [Supplement](#note-ZOI190335-1-s){ref-type="supplementary-material"}).

Four studies directly compared incidence of prefrailty among 4003 men and 3655 women who survived a median follow-up of 4.2 years. In all, 32.6% (1305 of 4003) of the men and 40.1% (1465 of 3655) of the women became prefrail, at a pooled incidence rate of 129.0 (95% CI, 73.8-225.0; *I*^2^ = 98.5%) and 173.2 (95% CI, 87.9-341.2; *I*^2^ = 99.1%) cases per 1000 person-years, respectively (*P* for difference = .12). No study reported age-stratified prefrailty incidence data.

Meta-regression {#H2-9-ZOI190335}
---------------

In the multivariable random-effects meta-regression, measuring frailty as a physical phenotype was associated with higher incidence than using other methods (adjusted odds ratio \[aOR\], 1.48; 95% CI, 1.02-2.15), although no statistically significant difference was observed for prefrailty incidence ([Table 2](#zoi190335t2){ref-type="table"}). Study region was not significantly associated with frailty and prefrailty incidence, but HICs were associated with a lower incidence of frailty (aOR, 0.63; 95% CI, 0.42-0.95) and prefrailty (aOR, 0.30; 95% CI, 0.21-0.84) compared with LMICs. Studies published after 2009 were associated with lower frailty incidence. The variables included in the multivariable models collectively explained about 63.9% and 38.1% of the between-study variance for frailty and prefrailty incidence, respectively.

###### Results of Univariable and Multivariable Random-Effects Meta-regression of the Sources of Between-Study Heterogeneity

  Variable                                      Univariable        Multivariable                                               
  --------------------------------------------- ------------------ --------------- ------------------ ------------------ ----- ------
  **Incidence of Frailty**                                                                                                     
  Measurement method                                                                                                           63.9
  Physical phenotype                            1 \[Reference\]    NA              10.1               1 \[Reference\]    NA    
  Other                                         1.78 (1.09-2.89)   .02             1.48 (1.02-2.15)   .03                      
  Country income level                                                                                                         
  LMIC                                          1 \[Reference\]    NA              7.6                1 \[Reference\]    NA    
  HIC                                           0.59 (0.36-0.97)   .04             0.63 (0.42-0.95)   .03                      
  Study region                                                                                                                 
  North America                                 1 \[Reference\]    NA              1.2                1 \[Reference\]    NA    
  Europe                                        0.83 (0.52-1.32)   .43             0.88 (0.63-1.24)   .45                      
  Asia                                          0.99 (0.59-1.67)   .98             0.74 (0.50-1.10)   .13                      
  Other                                         1.45 (0.84-2.50)   .18             1.23 (0.82-1.84)   .31                      
  Person-years of follow-up per unit increase   0.99 (0.99-1.00)   .17             1.8                0.99 (0.99-0.99)   .02   
  Enrolled only elderly people (≥70 y)                                                                                         
  No                                            1 \[Reference\]    NA              −2.1               1 \[Reference\]    NA    
  Yes                                           1.08 (0.69-1.67)   .34             1.18 (0.85-1.63)   .31                      
  Study population                                                                                                             
  Mix                                           1 \[Reference\]    NA              5.8                1 \[Reference\]    NA    
  Female only                                   1.13 (0.64-2.00)   .67             1.14 (0.72-1.79)   .57                      
  Male only                                     0.52 (0.27-0.97)   .04             0.55 (0.35-0.87)   .01                      
  Publication years                                                                                                            
  2009 Or earlier                               1 \[Reference\]    \<.001          29.1               1 \[Reference\]    NA    
  2010-2014                                     0.27 (0.14-0.54)   \<.001          0.24 (0.14-0.44)   \<.001                   
  2015-2019                                     0.50 (0.27-0.95)   .03             0.42 (0.22-0.77)   .007                     
  **Incidence of Prefrailty**                                                                                                  
  Measurement method                                                                                                           38.1
  Physical phenotype                            1 \[Reference\]    NA              −1.7               1 \[Reference\]    NA    
  Other                                         0.65 (0.23-1.79)   .40             0.45 (0.18-1.16)   NA                       
  Country income level                                                                                                         
  LMIC                                          1 \[Reference\]    NA              18.4               1 \[Reference\]    NA    
  HIC                                           0.39 (0.17-0.90)   .03             0.30 (0.21-0.84)   .03                      
  Study region                                                                                                                 
  North America                                 1 \[Reference\]    NA              −10.8              1 \[Reference\]    NA    
  Europe                                        1.61 (0.63-4.10)   .24             1.66 (0.62-4.49)   .28                      
  Asia                                          1.91 (0.63-5.82)   .24             1.14 (0.33-3.90)   .82                      
  Other                                         1.22 (0.39-3.79)   .72             0.56 (0.15-2.15)   .36                      
  Person-years of follow-up per unit increase   1.00 (0.99-1.00)   .07             11.2               1.00 (0.99-1.00)   .21   
  Enrolled only elderly people (≥70 y)                                                                                         
  No                                            1 \[Reference\]    NA              1.8                1 \[Reference\]    NA    
  Yes                                           1.76 (0.64-4.81)   .26             1.40 (0.44-4.47)   .54                      
  Study population                                                                                                             
  Mix                                           1 \[Reference\]    NA              −0.1               1 \[Reference\]    NA    
  Female only                                   1.47 (0.44-4.93)   .51             1.02 (0.21-4.89)   .98                      
  Male only                                     0.69 (0.14-3.50)   .64             0.49 (0.13-1.81)   .25                      
  Publication years                                                                                                            
  2009 Or earlier                               1 \[Reference\]    NA              2.8                1 \[Reference\]    NA    
  2010-2014                                     0.33 (0.06-1.95)   .21             0.49 (0.09-2.86)   .39                      
  2015-2019                                     0.56 (0.11-2.99)   .48             0.76 (0.11-5.25)   .76                      

Abbreviations: aOR, adjusted odds ratio; HIC, high-income country; LMIC, lower-income and middle-income country; NA, not applicable; OR, odds ratio.

Discussion {#H1-4-ZOI190335}
==========

We performed a systematic review and meta-analysis to estimate the incidence of frailty and prefrailty among community-dwelling older adults. Our results indicate the following: (1) frailty and prefrailty incidence rates were approximately 43 and 151 new cases per 1000 person-years, respectively; (2) the incidence of frailty and prefrailty was higher in women than men; and (3) the incidence of frailty and prefrailty varied by frailty measurement method used and by country income level.

Although not necessarily synonymous with aging, frailty is highly prevalent among older people.^[@zoi190335r3],[@zoi190335r4]^ Our pooled baseline data suggested that approximately 1 in 6 community-dwelling older people may have frailty. Frailty has been associated with adverse health outcomes, such as falls, disability, and death, as well as increased use of health care resources.^[@zoi190335r8],[@zoi190335r9],[@zoi190335r12]^ Therefore, efforts to reduce the burden of frailty could have substantial public health consequences.

Prevention of frailty requires a sound understanding of the risk factors. For example, it has been demonstrated that individual chronic diseases (eg, cancers, type 2 diabetes,^[@zoi190335r63],[@zoi190335r66],[@zoi190335r71]^ and depression,^[@zoi190335r77],[@zoi190335r85],[@zoi190335r87]^ or their co-occurrence \[ie, multimorbidity\]) have been shown to increase the risk of frailty.^[@zoi190335r88],[@zoi190335r89]^ With an estimated 66% of older people having at least 2 chronic medical conditions,^[@zoi190335r90]^ effective preventive strategies are paramount to reduce overall disease burden. The rising prevalence of obesity among older adults^[@zoi190335r91],[@zoi190335r92]^ needs greater attention because this condition, particularly abdominal obesity, may increase the risk of frailty through the association with proinflammatory processes, insulin resistance, fat infiltration of skeletal muscles, and hormonal alterations.^[@zoi190335r93],[@zoi190335r94]^ Many other sociodemographic, physical, biological, lifestyle (eg, smoking), and psychological factors may equally contribute to the development of frailty and thus require tailored solutions in different settings.^[@zoi190335r95],[@zoi190335r96],[@zoi190335r97],[@zoi190335r98]^

We found a higher incidence of frailty and prefrailty in LMICs than HICs in our study, which is consistent with prior observations of significantly higher prevalence of frailty and prefrailty in LMICs compared with HICs.^[@zoi190335r99]^ Some studies^[@zoi190335r59],[@zoi190335r87],[@zoi190335r100]^ found that high income and educational levels and greater access to and quality of health care confer lower frailty risk, which may partly explain the disparity in frailty incidence between LMICs and HICs, presenting opportunity to prevent or delay the onset of chronic pathologies associated with increased risk of frailty.^[@zoi190335r88],[@zoi190335r101]^

Our meta-analysis suggests higher incidence of frailty and prefrailty in women than men. Previous studies have shown consistently higher prevalence rates^[@zoi190335r3],[@zoi190335r99]^ and frailty scores^[@zoi190335r102]^ among women than men across all age groups. The sex differences may be attributable to both biological and socioeconomic factors. Nonetheless, women have been found to better tolerate frailty, as evidenced by lower mortality rates at any frailty level or age, suggesting the existence of a male-female health-survival paradox.^[@zoi190335r102]^

To date, several interventions incorporating exercise, nutrition, cognitive training, geriatric assessment, hormone therapy, and management and prehabilitation have been evaluated for their effectiveness at delaying or reversing frailty.^[@zoi190335r103],[@zoi190335r104],[@zoi190335r105],[@zoi190335r106],[@zoi190335r107]^ Most of these interventions have demonstrated feasibility, with adherence rates of about 70%.^[@zoi190335r103]^ However, a recent systematic review reported that, among the available primary care interventions to delay or reverse frailty, strength training and protein supplementation ranked highest in terms of relative effectiveness and ease of implementation.^[@zoi190335r108]^ Conversely, mild-intensity mixed exercises, as well as educational or health promotion activities, typically were in the midzone for both relative effectiveness and ease of implementation, whereas comprehensive geriatric assessments and home visits were ranked mid to low for both relative effectiveness and ease of implementation. In general, interventions targeting behavioral change ranked low in relative effectiveness and at the midzone for ease of implementation.^[@zoi190335r108]^ However, it needs emphasizing that most interventions have been tested in people who were frail or prefrail.^[@zoi190335r103],[@zoi190335r108]^ Our meta-analysis showed that, among people who were robust, there were approximately 12 and 151 new cases of frailty and prefrailty per 1000 person-years, respectively, suggesting that interventions aimed at preventing frailty and prefrailty in robust populations could be important.

The lower pooled incidence when frailty was defined as a physical phenotype compared with when a broad phenotype was used is consistent with prior meta-analyses that have demonstrated higher frailty prevalence when using broad definitions vs the physical phenotype.^[@zoi190335r3],[@zoi190335r99]^ Other studies^[@zoi190335r3]^ have shown considerable variability in the literature regarding the use of the deficit accumulation approach (as also observed in the present study), thus contributing to wide estimates of frailty burden. Therefore, a harmonized definition of frailty may be useful.

Limitations and Future Directions {#H2-10-ZOI190335}
---------------------------------

Our study had some limitations. There was substantial heterogeneity of the included studies. Nonetheless, heterogeneity is often inevitable in meta-analyses of observational studies, and it does not necessarily invalidate the findings.^[@zoi190335r109]^ We decided a priori to pool incidence data across studies that met our inclusion criteria. Furthermore, potential sources of heterogeneity were investigated via subgroup and random-effects meta-regression, which showed considerable heterogeneity in incidence rates by frailty measurement method, country income level, and publication years of studies. Meta-analysis of incidence data is also complicated by variable duration of follow-up. We sought to overcome this by estimating person-years on the basis of the median follow-up duration. While this method is considered robust and is widely applied in the literature,^[@zoi190335r27],[@zoi190335r31],[@zoi190335r32],[@zoi190335r33]^ a more precise approach would have required the use of the actual data on person-years, which were unavailable in more than 90% of studies. While frailty incidence varies by age, we could not perform age-stratified analysis due to limited data, and we were unable to account for the influence of the mean age of participants in the individual studies in the regression models due to poor reporting. People who develop frailty or prefrailty may regress^[@zoi190335r27],[@zoi190335r36]^; however, the present analysis does not incorporate regression rates. Finally, our abstract screening may have missed relevant studies in which frailty was not the main focus, but which contained information on the incidence of frailty (eg, frailty as a covariate).

Overall, the study results reiterate the need for regular screening programs to assess older people's vulnerability to frailty development so that appropriate interventions can be implemented in a timely manner.^[@zoi190335r16]^ For example, frailty assessment could be considered as part of routine health screening or could be instituted as a part of the core services delivered to older people within primary health care and general practice settings.^[@zoi190335r41]^ Because not all older people develop frailty, future studies should examine protective factors against frailty so as to inform preventive strategies. Our data could also inform health care planning and design of preventive strategies. However, the inequality in the availability of frailty data according to geographical locations requires attention because it hampers the opportunity to reliably forecast the future trajectory of the global burden of frailty, which is needed to inform efficient planning and resource allocation, mindful of the growing aging population.^[@zoi190335r21]^

Conclusions {#H1-5-ZOI190335}
===========

There is a high risk of frailty among community-dwelling older adults, and we observed that the incidence of frailty varies by sex, region, country income level, and diagnostic criteria used. It is imperative to improve understanding of the factors that confer increased risk of frailty. This will help inform the design of interventions to prevent frailty or minimize its negative consequences on health.
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